Category IP Policies

IGF Needs Bold Reform, Internet Needs More Regulation, Says President Macron

PARIS -- French President Emmanuel Macron today opened the 13th Internet Governance Forum (November 12-14) in Paris with a firework of requests to the IGF community and some bold ideas. The IGF after a decade should take on much more responsibility in the development of internet regulation, Macron demanded, and said he together with last year’s and next year’s hosts of the UN forum is collaborating on pushing for more formal results, The IGF according to Macron should become a part of the UN Secretary General‘s Office, Macron proposed, to illustrate the importance. His call for regulation was echoed at the event by UN Secretary General Antonio Guterres.

Key Hepatitis C Drug Licensed To Medicines Patent Pool, Access Expanded For LMICs

A key drug to treat hepatitis C has been licensed to the Medicines Patent Pool, enabling generic production and expanding affordable access to the drug in low and middle-income countries, excluding the very largest. The agreement between the Pool and AbbVie had been over a year in the making, MPP Executive Director Charles Gore told Intellectual Property Watch.

WIPO Members Look At Protection Of Country Names, GIs, Icons

A number of countries are voicing concerns about their country name being used by trademark applicants with no relation to the country, riding on the country's reputation or geographical relevance. They are also worried about their country name being used as an internet top-level domain name. Those are among the issues being discussed this week at the World Intellectual Property Organization committee on trademarks, along with questions on the protection of geographical indications, and of icons and typeface on the internet.

WTO TRIPS Council Debates Competition Law, Plain Packaging’s Spread To Other Products

The World Trade Organization intellectual property committee met last week with lively discussions on the benefit of IP rights protection for new businesses, and on the role of competition law to prevent abuses of those rights and in particular ensure greater access to medicines. Also, considering the recent WTO Dispute Settlement Body ruling on the tobacco plain packaging, some countries warned against this decision becoming a precedent and spreading to other goods, and undermining trademark protection.

Experts Assess Coming Changes In US Courts And Patentability

NEW YORK -- A panel of legal and government experts this week discussed trends in courts in the United States on patent cases and changes underway at the US Patent and Trademark Office. One conclusion? There may be a real shift in what is seen as patentable in the US, but it may take an act of Congress. [Note: part 1 of 2. The second part will address this week's changes in the US Congress.]

Intangible Capital Rising, IP Key For Start-Ups, Traditional Growth Model Has To Change, Panellists Say

The importance of intangible capital is growing and so is the significance of intellectual property, according to some, and in particular in the new economy. Start-ups see intellectual property as an indispensable tool to attract investors and put their innovations onto the market. Developing countries still mainly stuck in what some call the "commodity trap" have to identify and exploit their intellectual property assets, according to panellists at an event held at the World Trade Organization yesterday.

New EU Directive Limits Hate Speech, Establishes European Content Quotas

A new directive adopted today by European Union member governments updates and strengthens regulations on video-sharing platforms and other newer forms of media, emphasising the public interest, elevating protections for children, and establishing a 30 percent quota of European content in on-demand audiovisual media services.

Report Finds “Overpatenting”, Overpricing Of Top Diabetes Drug In US

Non-profit patent researchers studying the most prominent prescription insulin drug to treat diabetes in the United States found it is “overpatented” and “overpriced,” enabling unwarranted price-hikes resulting in rising costs for patients and taxpayers.